Hoffmann-La Roche: Osteoporosis, Postmenopausal trials

The registry lists 22 Osteoporosis, Postmenopausal studies with Hoffmann-La Roche as lead sponsor. 0 are open to participants now and 12 have results posted.

Phase 3 4Phase 4 14No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal OsteoporosisCompletedNCT02598934Phase 4Results posted
• A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal OsteoporosisCompletedNCT01290094Phase 3Results posted
• A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva TreatmentCompletedNCT00551174Phase 4Results posted
• BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.CompletedNCT00545779Phase 3Results posted
• A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)CompletedNCT00545363Phase 4Results posted
• A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.CompletedNCT00545051Phase 4Results posted
• A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.CompletedNCT00503113Phase 4Results posted
• A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.CompletedNCT00377234Phase 4Results posted
• A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)CompletedNCT00303485Phase 4Results posted
• A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With BonvivaCompletedNCT00081653Phase 4Results posted
• DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal OsteoporosisCompletedNCT00048074Phase 3Results posted
• MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal OsteoporosisCompletedNCT00048061Phase 3Results posted
• Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal OsteoporosisStatus unknownNCT05433207
• A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or OsteopeniaCompletedNCT02604836Phase 4
• PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or OsteopeniaCompletedNCT02598453Phase 4
• A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal OsteoporosisCompletedNCT02598440Phase 4
• Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in PakistanCompletedNCT02422069
• A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal OsteoporosisCompletedNCT01128257
• BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal OsteoporosisCompletedNCT00545909Phase 4
• SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.CompletedNCT00545480Phase 4
• ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.CompletedNCT00545090Phase 4
• A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.No longer availableNCT00493532